These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32989391)

  • 1. Tac2-N serves an oncogenic role and promotes drug resistance in human gastric cancer cells.
    Shen L; Zhang P; Wang J; Ji P
    Exp Ther Med; 2020 Nov; 20(5):113. PubMed ID: 32989391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TC2N is associated with poor prognosis in gastric cancer.
    Xu J; Ou X; Li J; Cai Q; Sun K; Ye J; Peng J
    J Cancer; 2021; 12(3):807-817. PubMed ID: 33403038
    [No Abstract]   [Full Text] [Related]  

  • 3. TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.
    Hao XL; Han F; Zhang N; Chen HQ; Jiang X; Yin L; Liu WB; Wang DD; Chen JP; Cui ZH; Ao L; Cao J; Liu JY
    Cell Death Differ; 2019 Jul; 26(7):1235-1250. PubMed ID: 30254375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway.
    Zhang Z; Ning M; Li L; Li Z; Wang Y; Zhao J
    Oncol Lett; 2023 Jun; 25(6):242. PubMed ID: 37153049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tac2-N Promotes Glioma Proliferation and Indicates Poor Clinical Outcomes.
    Dou Y; Xu H; Wu X; Liu P
    Tohoku J Exp Med; 2021 Nov; 255(3):247-256. PubMed ID: 34840225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of deferasirox as a novel therapeutic modality in gastric cancer.
    Choi JH; Kim JS; Won YW; Uhm J; Park BB; Lee YY
    World J Surg Oncol; 2016 Mar; 14():77. PubMed ID: 26965928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
    Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of myosin VI regulates gastric cancer cell progression.
    Wang Z; Ying M; Wu Q; Wang R; Li Y
    Gene; 2016 Nov; 593(1):100-109. PubMed ID: 27515005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer
    Lin J; Chen Z; Huang Z; Chen F; Ye Z; Lin S; Wang W
    Exp Ther Med; 2017 Nov; 14(5):4194-4200. PubMed ID: 29104635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin ligase CHIP modulates cellular behaviors of gastric cancer cells by regulating TRAF2.
    Dai H; Chen H; Xu J; Zhou J; Shan Z; Yang H; Zhou X; Guo F
    Cancer Cell Int; 2019; 19():132. PubMed ID: 31130821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells.
    Xia Y; Yan Z; Wan Y; Wei S; Bi Y; Zhao J; Liu J; Liao DJ; Huang H
    Mol Med Rep; 2018 Sep; 18(3):3375-3381. PubMed ID: 30066922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic role of LYN in human gastric cancer via the Wnt/β-catenin and AKT/mTOR pathways.
    Su R; Zhang J
    Exp Ther Med; 2020 Jul; 20(1):646-654. PubMed ID: 32509024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-butyltryptophan inhibits cell proliferation, migration, and invasion through the Akt pathway in human gastric cancer cells.
    Sun T; Tian H; Xin Y
    Tumour Biol; 2015 Apr; 36(4):2517-22. PubMed ID: 25433499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pPe
    Yang YL; Gong WY; Chen FF; Chen LC; Chen YT
    Oncol Lett; 2017 Jul; 14(1):533-540. PubMed ID: 28693202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of RAI14 suppresses the progression of gastric cancer.
    Chen C; Maimaiti A; Zhang X; Qu H; Sun Q; He Q; Yu W
    Onco Targets Ther; 2018; 11():6693-6703. PubMed ID: 30349303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrase interactor 1 regulates proliferation, apoptosis and invasion in gastric cancer cells.
    Wang XC; Li Y; Fan LQ; Tan BB; Li Z; Liu Y; Zhang ZD
    Chin Med J (Engl); 2012 Feb; 125(3):527-32. PubMed ID: 22490415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma.
    Hu Q; Li L; Zou X; Xu L; Yi P
    Front Pharmacol; 2018; 9():1150. PubMed ID: 30405404
    [No Abstract]   [Full Text] [Related]  

  • 19. Long non-coding RNA
    Gao C; Wu X; Zhai J; Shen J; Wang S; Shen L
    Transl Cancer Res; 2019 Apr; 8(2):520-531. PubMed ID: 35116784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
    Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
    Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.